56 related articles for article (PubMed ID: 19776495)
1. Poly (ADP-Ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE-/- mice with hyperhomocysteinemia.
Xie JJ; Yu X; Liao YH; Chen J; Yao R; Chen Y; Liao MY; Ding YJ; Tang TT; Cheng X
J Atheroscler Thromb; 2009 Oct; 16(5):641-53. PubMed ID: 19776495
[TBL] [Abstract][Full Text] [Related]
2. Exercise intervention attenuates hyperhomocysteinemia-induced aortic endothelial oxidative injury by regulating SIRT1 through mitigating NADPH oxidase/LOX-1 signaling.
Chan SH; Hung CH; Shih JY; Chu PM; Cheng YH; Lin HC; Hsieh PL; Tsai KL
Redox Biol; 2018 Apr; 14():116-125. PubMed ID: 28888894
[TBL] [Abstract][Full Text] [Related]
3. Absence of poly(ADP-ribose)polymerase-1 alters nuclear factor-kappa B activation and gene expression of apoptosis regulators after reperfusion injury.
Zingarelli B; Hake PW; O'Connor M; Denenberg A; Kong S; Aronow BJ
Mol Med; 2003; 9(5-8):143-53. PubMed ID: 14571322
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model.
Hofmann MA; Lalla E; Lu Y; Gleason MR; Wolf BM; Tanji N; Ferran LJ; Kohl B; Rao V; Kisiel W; Stern DM; Schmidt AM
J Clin Invest; 2001 Mar; 107(6):675-83. PubMed ID: 11254667
[TBL] [Abstract][Full Text] [Related]
5. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
Pacher P; Szabó C
Cardiovasc Drug Rev; 2007; 25(3):235-60. PubMed ID: 17919258
[TBL] [Abstract][Full Text] [Related]
6. Nuclear FAK in endothelium: An intrinsic inhibitor of NF-κB activation in atherosclerosis.
Murphy JM; Jeong K; Tran DTK; Cioffi DL; Campbell PM; Kim JH; Jo H; Ahn EE; Lim SS
Atherosclerosis; 2023 Aug; 379():117189. PubMed ID: 37527611
[TBL] [Abstract][Full Text] [Related]
7. Altered gene expression in early atherosclerosis is blocked by low level apolipoprotein E.
Ma Y; Malbon CC; Williams DL; Thorngate FE
PLoS One; 2008 Jun; 3(6):e2503. PubMed ID: 18560564
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.
Drel VR; Pacher P; Stavniichuk R; Xu W; Zhang J; Kuchmerovska TM; Slusher B; Obrosova IG
Int J Mol Med; 2011 Oct; 28(4):629-35. PubMed ID: 21617845
[TBL] [Abstract][Full Text] [Related]
9. The protective mechanism of folic acid on hyperhomocysteinemia-related arterial injury in spontaneously hypertensive rats: Folic acid against arterial inflammation.
Zhang L; Li Z; Xing C; Ma X; Xu R
Vascular; 2022 Oct; 30(5):988-998. PubMed ID: 34362270
[TBL] [Abstract][Full Text] [Related]
10. Impact of Probiotic Lactiplantibacillus plantarum ATCC 14917 on atherosclerotic plaque and its mechanism.
Hassan A; Luqman A; Zhang K; Ullah M; Din AU; Xiaoling L; Wang G
World J Microbiol Biotechnol; 2024 May; 40(7):198. PubMed ID: 38727952
[TBL] [Abstract][Full Text] [Related]
11. Hyperoside attenuates carbon tetrachloride-induced hepatic fibrosis via the poly(ADP-ribose)polymerase-1-high mobility group protein 1 pathway.
Zeng HH; Ma M; Wang YL; Chen MH; Huang DB
Eur J Pharmacol; 2023 Dec; 960():176178. PubMed ID: 37923159
[TBL] [Abstract][Full Text] [Related]
12. [Research progress on the role and mechanism of endothelial dysfunction in hyperhomocysteine-induced atherosclerosis].
Wu CY; Duan XL; Wang LB; Wang XH
Sheng Li Xue Bao; 2023 Oct; 75(5):703-713. PubMed ID: 37909141
[TBL] [Abstract][Full Text] [Related]
13. Consumption of Cashew (
D'Amico R; Cordaro M; Fusco R; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Mandalari G; Caccamo D; Cuzzocrea S; Di Paola R; Siracusa R; Impellizzeri D
Nutrients; 2022 Apr; 14(7):. PubMed ID: 35406088
[TBL] [Abstract][Full Text] [Related]
14. UV-B- and oxidative stress-induced increase in nicotinamide and trigonelline and inhibition of defensive metabolism induction by poly(ADP-ribose)polymerase inhibitor in plant tissue.
Berglund T; Kalbin G; Strid A; Rydström J; Ohlsson AB
FEBS Lett; 1996 Feb; 380(1-2):188-93. PubMed ID: 8603735
[TBL] [Abstract][Full Text] [Related]
15. Chemical PARP inhibition enhances growth of Arabidopsis and reduces anthocyanin accumulation and the activation of stress protective mechanisms.
Schulz P; Neukermans J; Van der Kelen K; Mühlenbock P; Van Breusegem F; Noctor G; Teige M; Metzlaff M; Hannah MA
PLoS One; 2012; 7(5):e37287. PubMed ID: 22662141
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomics Analysis Revealed Key Genes Associated with Macrophage Autophagolysosome in Male ApoE
Zhu M; Jin T; Wu D; Zhang S; Wang A
J Inflamm Res; 2023; 16():5125-5144. PubMed ID: 37965353
[TBL] [Abstract][Full Text] [Related]
17. The association between hyperhomocysteinemia and the prevalence of bilateral carotid atherosclerotic plaques in a middle-aged population.
Yong Y; Dong H; Zhu Y; Gu M; Li W; Jiang W; Lv J
Clin Neurol Neurosurg; 2024 May; 243():108361. PubMed ID: 38851120
[TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory properties of vinpocetine mediates its therapeutic potential in management of atherosclerosis.
Alshehri AA; Al-Kuraishy HM; Al-Gareeb AI; Jawad SF; Khawagi WY; Alexiou A; Papadakis M; Assiri AA; Elhadad H; El-Saber Batiha G
J Inflamm (Lond); 2024 Jun; 21(1):19. PubMed ID: 38858751
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia, Suppressed Immunity, and Altered Oxidative Metabolism Caused by Pathogenic Microbes in Atherosclerosis and Dementia.
McCully KS
Front Aging Neurosci; 2017; 9():324. PubMed ID: 29056905
[TBL] [Abstract][Full Text] [Related]
20. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets.
De Meyer GRY; Zurek M; Puylaert P; Martinet W
Nat Rev Cardiol; 2024 May; 21(5):312-325. PubMed ID: 38163815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
